blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1921067

EP1921067 - Indole and indazole derivatives as anti-inflammatory agents [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.04.2009
Database last updated on 19.10.2024
Most recent event   Tooltip24.04.2009Application deemed to be withdrawnpublished on 27.05.2009  [2009/22]
Applicant(s)For all designated states
Bayer Schering Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2008/20]
Inventor(s)01 / Berger, Markus
Malplaquetstrasse 35
13347 Berlin / DE
02 / Rehwinkel, Hartmut
Blücherstrasse 13
10961 Berlin / DE
03 / Schäcke, Heike
Gartenstrasse 105
10115 Berlin / DE
04 / Lepistö, Matti
Borgaslingan 18
22742 Lund / SE
05 / Edmann, Karl
Engelbrektsgatan 41
41137 Göteborg / SE
 [2008/20]
Representative(s)Seuss, Thomas, et al
Jungblut & Seuss
Patentanwälte
Wittestraße 30 J
13509 Berlin / DE
[N/P]
Former [2008/33]Seuss, Thomas, et al
JUNGBLUT & SEUSS Patentanwälte Max-Dohrn-Strasse 10
10589 Berlin / DE
Former [2008/20]Seuss, Thomas, et al
JUNGBLUT & SEUSS Patentanwälte Max-Dohrn-Strasse 10
10589 Berlin / DE
Application number, filing date06090203.808.11.2006
[2008/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1921067
Date:14.05.2008
Language:EN
[2008/20]
Search report(s)(Supplementary) European search report - dispatched on:EP12.04.2007
ClassificationIPC:C07D231/56, C07D401/04, C07D405/12, C07D405/14, A61K31/41, A61K31/435, A61P29/00
[2008/20]
CPC:
C07D405/12 (EP,US); A61P29/00 (EP); C07D231/56 (EP,US);
C07D401/04 (EP,US); C07D405/14 (EP,US)
Designated contracting states[2009/04]
Former [2008/20]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Indol- und Indazolderivate als Entzündungshemmer[2008/20]
English:Indole and indazole derivatives as anti-inflammatory agents[2008/20]
French:Dérivés d'indole et d'indazole comme agents anti-inflammatoires[2008/20]
Examination procedure15.11.2008Application deemed to be withdrawn, date of legal effect  [2009/22]
29.12.2008Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2009/22]
Fees paidRenewal fee
22.10.2008Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DX]WO2006108699  (GLAXO GROUP LTD [GB], et al) [DX] 1-18 * abstract *;
 [DA]WO03082280  (BOEHRINGER INGELHEIM PHARMA [US]) [DA] 1-18 * the whole document *;
 [DA]WO2005003098  (SCHERING AG [DE]) [DA] 1-18 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.